Effects of tanshinone VI on insulin-like growth factor-1-induced hypertrophy of isolated cardiomyocytes from neonatal rats.

Yuji Kawahara, Kouichi Tanonaka, Toru Arino, Toshiyuki Maki, Naoko Ishihara, Norio Takagi, Akira Yagi, Satoshi Takeo
Author Information
  1. Yuji Kawahara: Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Hachioji, Tokyo and.

Abstract

The effects of tanshinone VI (Tan), a diterpene extracted from Salvia miltiorrhiza, on insulin-like growth factor-1 (IGF-1)-induced hypertrophy of cardiomyocytes were examined. Cultured cardiomyocytes were isolated from neonatal rat hearts. The incorporation of [(3)H]-leucine into the trichloroacetic acid (TCA)-insoluble fraction was measured as a marker of protein synthesis, which revealed cardiomyocyte hypertrophy. Various concentrations of IGF-1, ranging from 0.1 nM to 10 nM, increased [(3)H]-leucine incorporation into the TCA-insoluble fraction of cardiomyocytes in a dose-dependent manner. IGF-1 induced an increase in phosphorylated extracellular signal-regulated kinase 1/2 (ERK), but did not change ERK protein content in cardiomyocytes. When the cells were incubated in the presence of Tan (0.1 muM to 10 muM), [(3)H]-leucine incorporation into IGF-1-untreated cells was unaltered. When the cells were incubated with 10 muM Tan, IGF-1-induced increases in [(3)H]-leucine incorporation into the TCA-insoluble fraction and phosphorylated ERK were attenuated. These results suggest that Tan is a possible agent for the suppression of IGF-1-induced hypertrophy of cardiomyocytes via an attenuation of ERK activation.

Keywords

References

  1. J Biol Chem. 1997 Aug 1;272(31):19115-24 [PMID: 9235900]
  2. Cardiovasc Res. 2001 Apr;50(1):34-45 [PMID: 11282076]
  3. Cell Regul. 1991 May;2(5):357-71 [PMID: 1654126]
  4. Pharmacol Res. 1999 Dec;40(6):487-91 [PMID: 10660946]
  5. Circulation. 1996 Feb 15;93(4):800-9 [PMID: 8641010]
  6. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8205-9 [PMID: 1381507]
  7. J Biol Chem. 1951 Nov;193(1):265-75 [PMID: 14907713]
  8. Nature. 1970 Aug 15;227(5259):680-5 [PMID: 5432063]
  9. Circulation. 1999 Dec 7;100(23):2373-9 [PMID: 10587343]
  10. Mol Endocrinol. 1994 May;8(5):539-44 [PMID: 8058064]
  11. Biochem Pharmacol. 2002 Aug 15;64(4):745-9 [PMID: 12167494]
  12. Biochem Biophys Res Commun. 1998 Feb 4;243(1):20-4 [PMID: 9473472]
  13. Biochem Pharmacol. 1990 Sep 1;40(5):1137-43 [PMID: 2390109]
  14. Jpn J Pharmacol. 2001 Dec;87(4):289-96 [PMID: 11829148]
  15. Eur J Endocrinol. 2000 Mar;142(3):211-6 [PMID: 10700713]
  16. J Biol Chem. 1992 Mar 5;267(7):4747-51 [PMID: 1537856]
  17. J Biol Chem. 1992 Jan 15;267(2):1088-92 [PMID: 1730637]
  18. Planta Med. 1989 Feb;55(1):51-4 [PMID: 2717690]
  19. Br J Pharmacol. 2000 Nov;131(6):1204-10 [PMID: 11082129]
  20. Planta Med. 1994 Oct;60(5):405-9 [PMID: 7997465]
  21. FEBS Lett. 1998 Jan 30;422(2):193-6 [PMID: 9490004]
  22. Endocrinology. 2001 Jan;142(1):332-8 [PMID: 11145596]

Word Cloud

Created with Highcharts 10.0.0cardiomyocytesTanhypertrophyincorporation[3H]-leucineERKVIgrowthIGF-1fraction10cellsmuMtanshinoneinsulin-likefactor-1isolatedneonatalprotein01nMTCA-insolublephosphorylatedsignal-regulatedkinase1/2incubatedIGF-1-inducedeffectsditerpeneextractedSalviamiltiorrhiza-inducedexaminedCulturedratheartstrichloroaceticacidTCA-insolublemeasuredmarkersynthesisrevealedcardiomyocyteVariousconcentrationsrangingincreaseddose-dependentmannerinducedincreaseextracellularchangecontentpresenceIGF-1-untreatedunalteredincreasesattenuatedresultssuggestpossibleagentsuppressionviaattenuationactivationEffectsfactor-1-inducedratsCardiomyocytesExtracellularHypertrophyInsulin-likeTanshinone

Similar Articles

Cited By